Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04019548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

Study acronym: SwallPEG
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Apr 1, 2023 to Nov 1, 2027 Completion date: Oct 1, 2026 to May 1, 2030v5 Show 1 more changeShow less
    • Completion date: Oct 1, 2026 to May 1, 2030
  2. Re-verified, no change to tracked fieldsv4
  3. Study sites: 1 to 2 Start date changed from estimate of Oct 1, 2019 to Dec 16, 2019v3 Show 1 more changeShow less
    • Start date changed from estimate of Oct 1, 2019 to Dec 16, 2019
  4. Trial status: Not Yet Recruiting to Recruiting Start date: Aug 1, 2019 to Oct 1, 2019v2 Show 1 more changeShow less
    • Start date: Aug 1, 2019 to Oct 1, 2019
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Open-label, interventional, multicentric, randomized, phase III study. Cancer studied is the oropharyngeal cancer. Study is composed by 2 arms of subjects: prophylactic or reactive percutaneous endoscopic gastrostomy tube placement. All subjects will be treated with a cisplatin standard chemotherapy regimen and by simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT).
Trial Details
NCT Number NCT04019548
Lead Sponsor Jules Bordet Institute
Conditions Oropharyngeal Cancer
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov